"resumption of Marmota’s uranium program, for the clear benefit of our shareholders … some of whom first invested in Marmota when it started life exclusively as a very successful uranium explorer."
I'd be one and finally resuming exploration in those tenements at long last.
Doesn't seem like much is going to happen at AT in the short term.
Interesting the Auditor highlights this.... "Carrying value of exploration and evaluation assets" ... as a concern they investigated.
- Forums
- ASX - By Stock
- Ann: 2023 Annual Financial Statements
MEU
marmota limited
Add to My Watchlist
5.26%
!
4.0¢

"resumption of Marmota’s uranium program, for the clear benefit...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $47.13M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $7.852K | 199.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 44055 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 817481 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 44055 | 0.039 |
5 | 245676 | 0.038 |
10 | 702485 | 0.037 |
4 | 430250 | 0.036 |
6 | 560742 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 817481 | 5 |
0.041 | 106541 | 2 |
0.042 | 352531 | 2 |
0.043 | 109756 | 1 |
0.044 | 100000 | 1 |
Last trade - 15.32pm 01/07/2025 (20 minute delay) ? |
Featured News
MEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online